Suchergebnisse - (Subject:"Drug repurposing")

PubPharm (534)

91

In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach : Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19

enthalten in: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2022

von Mirmohammadi, S. | Kianmehr, A. | Sabbaghian, A. | +4

ErratumIn: Infect Genet Evol. 2022 Oct;104:105361. - PMID 36089457

92

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Awad, H. | Hassan, B. | Dweek, S. | +3

93

In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment

enthalten in: Vaccines | 2022

von Wotring, J. | McCarty, S. | Shafiq, K. | +9

UpdateOf: bioRxiv. 2022 Jul 13;:. - PMID 35860224

94

A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics

enthalten in: Expert review of clinical pharmacology | 2022

von Wattanakul, T. | Chotsiri, P. | Scandale, I. | +2

95

Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods

enthalten in: Computers in biology and medicine | 2022

von Ebrahimi, M. | Karami, L. | Alijanianzadeh, M.

96

Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2

enthalten in: Structural chemistry | 2022

von Niranjan, V. | Setlur, A. | Karunakaran, C. | +3

97

Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2

enthalten in: Structural chemistry | 2022

von Niranjan, V. | Setlur, A. | Karunakaran, C. | +3

98

Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2

enthalten in: Structural chemistry | 2022

von Niranjan, V. | Setlur, A. | Karunakaran, C. | +3

99

Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor : an in silico drug repurposing study

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Ahmadi, K. | Farasat, A. | Rostamian, M. | +2

100

In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2

enthalten in: Computers in biology and medicine | 2022

von Chakraborty, R. | Bhattacharje, G. | Baral, J. | +8